Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, announced today that it has appointed Christopher Kay as Senior Vice President and Chief Innovation Officer, effective March 17. Kay will report to President and Chief Executive Officer Bruce Broussard and serve on the company’s Management Team.
In his new role, Kay will lead the company’s innovation strategy. Among other priorities, he will focus on innovations in personalized health designed to simplify the health care experience, leading to better health outcomes.
“Chris is a keen innovator with a passion for creating new businesses in large organizations, and for launching products and services that enhance the consumer experience,” Broussard said. “He brings a wealth of experience in consumer-facing industries to a pivotal role that is vital to Humana’s future success.”
“I am honored to join a leading-edge company that is dedicated to making healthcare easy for consumers while improving health outcomes,” Kay said. “I look forward eagerly to contributing to Humana’s dream of helping people achieve lifelong well-being.”Kay was most recently Managing Director and CEO of Citi Ventures, Citigroup’s global corporate venturing arm. At Citi Ventures, he pioneered efforts to simplify and improve the banking experience for Citi’s millions of customers through use of digital, mobile, data and other customer-centric solutions. Prior to joining Citi in 2007, Kay held several leadership positions at Target over a 12-year period. Kay holds a J.D., magna cum laude, from the University of Minnesota School of Law. He earned a B.A. in French and Economics from the University of Wisconsin-Madison. About Humana Humana Inc., headquartered in Louisville, Ky., is a leading health care company that offers a wide range of insurance products and health and wellness services that incorporate an integrated approach to lifelong well-being. By leveraging the strengths of its core businesses, Humana believes it can better explore opportunities for existing and emerging adjacencies in health care that can further enhance wellness opportunities for the millions of people across the nation with whom the company has relationships.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts